Notch signaling is inactive but inducible in human embryonic stem cells

Stem Cells

Volumn 24, Issue 7, 2006, Pages 1646-1653

  Noggle, Scott A ^a,c   Weiler, Deborah ^b   Condie, Brian G ^a  

^a University of Georgia ^*  (United States)

^b Georgia Biobusiness Center   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Secretase; Differentiation; Human development; Human embryonic stem cell; NOTCH intracellular domain HES

Indexed keywords

CATION; GAMMA SECRETASE INHIBITOR; NOTCH RECEPTOR; ASPARTIC PROTEINASE; BACE1 PROTEIN, HUMAN; CHELATING AGENT; PROTEINASE; SECRETASE;

ARTICLE; CANONICAL ANALYSIS; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL RENEWAL; CELL TYPE; CHELATION; CONTROLLED STUDY; EMBRYONIC STEM CELL; ENZYME INHIBITION; EXTRACELLULAR SPACE; HUMAN; HUMAN CELL; SIGNAL TRANSDUCTION; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; EMBRYO; METABOLISM; STEM CELL;

AMYLOID PRECURSOR PROTEIN SECRETASES; ASPARTIC ENDOPEPTIDASES; CATIONS; CELL DIFFERENTIATION; CELLS, CULTURED; CHELATING AGENTS; EMBRYO; ENDOPEPTIDASES; HUMANS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 33749074768     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2005-0314     Document Type: Article

References (40)

1. Sato N, Meijer L, Skaltsounis L et al. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med 2004;10:55-63.
2. Xu RH, Peck RM, Li DS et al. Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat Methods 2005;2:185-190.
3. Xu C, Rosler E, Jiang J et al. Basic fibroblast growth factor supports undifferentiated human embryonic stem cell growth without conditioned medium. STEM CELLS 2005;23:315-323.
4. Vallier L, Reynolds D, Pedersen RA. Nodal inhibits differentiation of human embryonic stem cells along the neuroectodermal default pathway. Dev Biol 2004;275:403-421.
5. Beattie GM, Lopez AD, Bucay N et al. Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers. STEM CELLS 2005;23:489-495.
6. James D, Levine AJ, Besser D et al. TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 2005;132:1273-1282.
7. Ginis I, Luo Y, Miura T et al. Differences between human and mouse embryonic stem cells. Dev Biol 2004;269:360-380.
8. Bieberich E, Silva J, Wang G et al. Selective apoptosis of pluripotent mouse and human stem cells by novel ceramide analogues prevents teratoma formation and enriches for neural precursors in ES cell-derived neural transplants. J Cell Biol 2004;167:723-734.
9. Mitalipova MM, Rao RR, Hoyer DM et al. Preserving the genetic integrity of human embryonic stem cells. Nat Biotechnol 2005;23:19-20.
10. Lai EC. Notch signaling: Control of cell communication and cell fate. Development 2004;131:965-973.
11. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: Cell fate control and signal integration in development. Science 1999;284:770-776.
12. Kadesch T. Notch signaling: The demise of elegant simplicity. Curr Opin Genet Dev 2004;14:506-512.
13. Walsh J, Andrews PW. Expression of Wnt and Notch pathway genes in a pluripotent human embryonal carcinoma cell line and embryonic stem cell. APMIS 2003;111:197-210; discussion 210-191.
14. Schulz TC, Noggle SA, Palmarini GM et al. Differentiation of human embryonic stem cells to dopaminergic neurons in serum-free suspension culture. STEM CELLS 2004;22:1218-1238.
15. Kornilova AY, Das C, Wolfe MS. Differential effects of inhibitors on the gamma-secretase complex. Mechanistic implications. J Biol Chem 2003;278:16470-16473.
16. Kornilova AY, Bihel F, Das C et al. The initial substrate-binding site of gamma-secretase is located on presenilin near the active site. Proc Natl Acad Sci U S A 2005;102:3230-3235.
17. Micchelli CA, Esler WP, Kimberly WT et al. Gamma-secretase/presenilin inhibitors for Alzheimer's disease phenocopy Notch mutations in Drosophila. FASEB J 2003;17:79-81.
18. Geling A, Steiner H, Willem M et al. A gamma-secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish. EMBO Rep 2002;3:688-694.
19. Yeh JR, Crews CM. Chemical genetics: Adding to the developmental biology toolbox. Dev Cell 2003;5:11-19.
20. Cheng HT, Miner JH, Lin M et al. Gamma-secretase activity is dispensable for mesenchyme-to-epithelium transition but required for podocyte and proximal tubule formation in developing mouse kidney. Development 2003;130:5031-5042.
21. van den Brandt J, Voss K, Schott M et al. Inhibition of Notch signaling biases rat thymocyte development towards the NK cell lineage. Eur J Immunol 2004;34:1405-1413.
22. Timmerman LA, Grego-Bessa J, Raya A et al. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev 2004;18:99-115.
23. De Smedt M, Hoebeke I, Reynvoet K et al. Different thresholds of Notch signaling bias human precursor cells toward B-, NK-, monocytic/dendritic-, or T-cell lineage in thymus microenvironment. Blood 2005;106:3498-3506.
24. Soriano S, Kang DE, Fu M et al. Presenilin 1 negatively regulates beta-catenin/T cell factor/lymphoid enhancer factor-1 signaling independently of beta-amyloid precursor protein and notch processing. J Cell Biol 2001;152:785-794.
25. Koo EH, Kopan R. Potential role of presenilin-regulated signaling pathways in sporadic neurodegeneration. Nat Med 2004;10(suppl):S26-S33.
26. Hsieh JJ, Henkel T, Salmon P et al. Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2. Mol Cell Biol 1996;16:952-959.
27. Xu C, Inokuma MS, Denham J et al. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol 2001;19:971-974.
28. Rand MD, Grimm LM, Artavanis-Tsakonas S et al. Calcium depletion dissociates and activates heterodimeric notch receptors. Mol Cell Biol 2000;20:1825-1835.
29. Brandenberger R, Khrebtukova I, Thies RS et al. MPSS profiling of human embryonic stem cells. BMC Dev Biol 2004;4:10.
30. Phiel CJ, Wilson CA, Lee VM et al. GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature 2003;423:435-439.
31. Cormier S, Vandormael-Pournin S, Babinet C et al. Developmental expression of the Notch signaling pathway genes during mouse preimplantation development. Gene Expr Patterns 2004;4:713-717.
32. Wang QT, Piotrowska K, Ciemerych MA et al. A genome-wide study of gene activity reveals developmental signaling pathways in the preimplantation mouse embryo. Dev Cell 2004;6:133-144.
33. Shi S, Stahl M, Lu L et al. Canonical notch signaling is dispensable for early cell fate specifications in mammals. Mol Cell Biol 2005;25:9503-9508.
34. Herreman A, Serneels L, Annaert W et al. Total inactivation of gamma-secretase activity in presenilin-deficient embryonic stem cells. Nat Cell Biol 2000;2:461-462.
35. Donoviel DB, Hadjantonakis AK, Ikeda M et al. Mice lacking both presenilin genes exhibit early embryonic patterning defects. Genes Dev 1999;13:2801-2810.
36. Hitoshi S, Alexson T, Tropepe V et al. Notch pathway molecules are essential for the maintenance, but not the generation, of mammalian neural stem cells. Genes Dev 2002;16:846-858.
37. McWhir J, Schnieke AE, Ansell R et al. Selective ablation of differentiated cells permits isolation of embryonic stem cell lines from murine embryos with a non-permissive genetic background. Nat Genet 1996;14:223-226.
38. Mountford P, Nichols J, Zevnik B et al. Maintenance of pluripotential embryonic stem cells by stem cell selection. Reprod Fertil Dev 1998;10:527-533.
39. Draper JS, Smith K, Gokhale P et al. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol 2004;22:53-54.
40. Buzzard JJ, Gough NM, Crook JM et al. Karyotype of human ES cells during extended culture. Nat Biotechnol 2004;22:381-382; author reply 382.